ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,820,106 | -42.6% | 214,448 | -35.0% | 0.04% | -35.8% |
| Q2 2023 | $10,146,293 | +1167.7% | 330,068 | +1385.9% | 0.07% | +1240.0% |
| Q1 2023 | $800,356 | -92.0% | 22,214 | -91.3% | 0.01% | -91.5% |
| Q4 2022 | $10,062,108 | +104.6% | 254,608 | +108.0% | 0.06% | +110.7% |
| Q3 2022 | $4,919,000 | +375.7% | 122,432 | +398.0% | 0.03% | +366.7% |
| Q2 2022 | $1,034,000 | -75.3% | 24,586 | -77.1% | 0.01% | -82.9% |
| Q1 2022 | $4,184,000 | +173.1% | 107,404 | +179.5% | 0.04% | +133.3% |
| Q4 2021 | $1,532,000 | -52.2% | 38,434 | -56.6% | 0.02% | -62.5% |
| Q3 2021 | $3,203,000 | -63.2% | 88,640 | -58.3% | 0.04% | -59.2% |
| Q2 2021 | $8,710,000 | +418.5% | 212,488 | +451.8% | 0.10% | +345.5% |
| Q1 2021 | $1,680,000 | +211.7% | 38,505 | +257.3% | 0.02% | +214.3% |
| Q4 2020 | $539,000 | -81.1% | 10,776 | -84.1% | 0.01% | -83.3% |
| Q3 2020 | $2,847,000 | +2040.6% | 67,665 | +2364.1% | 0.04% | +2000.0% |
| Q2 2020 | $133,000 | – | 2,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |